Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: Formation of intracellular lead-inclusion bodies and induction of apoptosis

Toxicology and Applied Pharmacology

Volumn 161, Issue 3, 1999, Pages 240-248

  Singh, Jatinder ^a   Pritchard, Daryl E ^a,b   Carlisle, Diane L ^a,b   McLean, John A ^b   Montaser, Akbar ^b   Orenstein, Jan M ^a,b   Patierno, Steven R ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Apoptosis; Carcinogenesis; Chromium; Lead chromate; Lead inclusion bodies; Lung; Metal DNA adducts; Toxicity

Indexed keywords

CHROMIUM; DNA; LEAD; LEAD CHROMATE; SODIUM CHROMATE;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CULTURE; CELL INCLUSION; CONTROLLED STUDY; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; HUMAN; HUMAN CELL; INTERNALIZATION; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; MASS SPECTROMETRY; OCCUPATIONAL EXPOSURE; PHAGOCYTOSIS; RESPIRATORY TRACT DISEASE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

RODENTIA;

EID: 0033573018     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8816     Document Type: Article

References (55)

1. 2, superoxide dismutase, and xanthine oxidase. Environ. Mol. Mutagen. 31:1998;352-361.
2. Blackman S. S. Intranuclear inclusion bodies in the kidney and liver caused by lead poisoning. Bull. Johns Hopkins Hosp. 58/59:1936;384-398.
3. Blankenship L. J., Carlisle D. L., Wise J. M., Orenstein J. M., Dye L. E., Patierno S. R. Induction of apoptotic cell death by particulate lead chromate: differential effects of vitamins C and E on genotoxicity and survival. Toxicol. Appl. Pharmacol. 146:1997;270-280.
4. Blankenship L. J., Manning F. C., Orenstein J. M., Patierno S. R. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol. 126:1994;75-83.
5. Bridgewater L. C., Manning F. C. R., Woa E. S., Patierno S. R. DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinog. 9:1994a;122-133.
6. Bridgewater L. C., Manning F. C. R., Patierno S. R. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking. Carcinogenesis. 15:1994b;2421-2427.
7. Bridgewater L. C., Manning F. C. R., Patierno S. R. Arrest of replication by mammalian DNA polymerases α and β caused by chromium-DNA lesions. Mol. Carcinog. 5:1998;201-206.
8. Calbrese E. J., Baldwin L. A. Lead-induced cell proliferation and organ-specific tumorigenicity. Drug Metab. Rev. 24:1992;409-416.
9. Casto B. C., Meyers J., Paolo J. A. Enhancement of viral transformation for evaluation of the carcinogenic or mutagenic potential of inorganic metal salts. Cancer Res. 39:1979;193-198.
10. De Flora S., Camoirano A., Bagnasco M., Benicelli C., Corbett G. E., Kerger B. D. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenesis. Carcinogenesis. 18:1997;531-537.
11. De Flora S., Wetterhahn K. E. Mechanisms of chromium metabolism and genotoxicity. Life Chem. Rep. 7:1989;169-244.
12. Douglas G. R., Bell R. D. L., Grant C. E., Wystma J. M., Bora K. C. Effect of lead chromate on chromosome aberration, sister-chromatide exchange and DNA damage in mammalian cells in vitro. Mutat. Res. 77:1980;157-163.
13. Elias Z., Poirot O., Pezerat H., Suquet H., Schneider O., Daniere M. C., Terzetti F., Baruthio F., Fournier M., Cavalier C. Cytotoxic and neoplastic transforming effects of industrial hexavalent chromium pigments in Syrian hamster embryo cells. Carcinogenesis. 10:1989;2043-2052.
14. Fox D. A., Campbell M. L., Blocker Y. S. Functional alterations and apoptotic cell death in the retina following developmental or adult lead exposure. Neurotoxicology. 18:1997;645-664.
15. Freeman N. C. G., Lioy P. J. Exposure to chromium dust from homes in a chromium surveillance project. Arch. Environ. Health. 52:1997;213-226.
16. Goyer R. A. Lead toxicity: current concerns. Environ. Health Perspect. 100:1993;177-187.
17. Goyer R. A., Leonard D. L., Moore J. F., Rhyne B., Krigman M. R. Lead dosage and the role of the intranuclear inclusion body: an experimental study. Arch. Environ. Health. 20:1970;705-711.
18. Hartwig A. Current aspects in metal genotoxicity. Biometals. 8:1995;3-11.
19. Hayes R. B. Review of occupational epidemiology of chromium chemicals and respiratory cancer. Sci. Total Environ. 71:1988;331-339.
20. Hsu F. S., Krook L., Shively J. N., Duncan J. R., Pond W. G. Lead inclusion bodies in osteoclasts. Science. 181:1973;447-448.
21. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 1980;IARC, Lyon. p. 325-416.
22. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 1990;IARC, Lyon. p. 49-256.
23. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., Tsuchiya E. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br. J. Cancer. 70:1994a;160-166.
24. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., Tsuchiya E. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 54:1994b;2342-2346.
25. Klein C. B., Frenkel K., Costa M. The role of oxidative processes in metal carcinogenesis. Chem. Res. Toxicol. 4:1991;592-604.
26. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17:1990;189-215.
27. Ljungman M., Zhang F. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. Oncogene. 13:1996;822-831.
28. Manning F. C. R., Blankenship L. J., Wise J. P., Xu J., Bridgewater L. C., Patierno S. R. Induction of internucleosomal DNA fragmentation by carcinogenic chromate: relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. Environ. Health Perpect. 102:1994;159-167.
29. Manning F. C. R., Xu J., Patierno S. R. Transcriptional inhibition by carcinogenic chromate: relationship to DNA damage. Mol. Carcinog. 6:1992;270-279.
30. Martin S. J., Reutelingsperger C. P. M., McGahon A. J., Rader J. A., van Schie R. C. A. A., LaFace D. M., Green D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1995;1545-1556.
31. McLachlin J. R., Goyer R. A., Cherian M. G. Formation of lead-induced inclusion bodies in primary rat kidney epithelial cell cultures: effect of actinomycin D and cycloheximide. Toxicol. Appl. Pharmacol. 56:1980;418-431.
32. McLean J. A., Zhang H., Montaser A. A direct injection high efficiency nebulizer for inductively coupled plasma mass spectrometry. Anal. Chem. 70:1998a;1012-1020.
33. McLean J. A., Minnich M. G., Lacone L. A., Liu H., Montaser A. Nebulizer diagnostics: fundamental parameters, challenges and techniques on the horizon. J. Anal. At. Spectrom. 13:1998b;829-842.
34. Meikrantz W., Schlegel R. Apoptosis and the cell cycle. J. Biol. Chem. 58:1995;160-174.
35. Montaser A. Inductively Coupled Plasma Mass Spectrometry. 1998;Wiley, New York.
36. Osheroff M. R., Uno H., Bowman R. E. Lead inclusion bodies in the anterior horn cells and neurons of the subtantia nigra in the adult rhesus monkey. Toxicol. Appl. Pharmacol. 64:1982;570-576.
37. Patierno S. R., Banh D., Landolph J. R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 48:1988;5280-5288.
38. Patierno S. R., Landolph J. R. Soluble vs. insoluble hexavalent chromate: relationship of mutation to in vitro transformation and particle uptake. Biol. Trace Elem. Res. 21:1989;469-474.
39. Ryberg D., Alexander J. Mechanisms of chromium toxicity. Chem.-Biol. Interact. 75:1990;141-151.
40. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Press, Cold Spring Harbor.
41. Singh J., McLean J. A., Pritchard D. E., Montaser A., Patierno S. R. Sensitive quantitation of chromium-DNA adducts by inductively-coupled plasma mass spectrometry with a direct injection nebulizer. Toxicol. Sciences. 46:1998a;260-265.
42. Singh J., Bridgewater L. C., Patierno S. R. Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA. Toxicol. Sciences. 45:1998b;72-76.
43. Singh J., Carlisle D. L., Pritchard D. E., Patierno S. R. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis. Oncology Reports. 5:1998c;1301-1318.
44. Singh J., Snow E. T. Chromium(III) decreases the fidelity of human DNA polymerase β Biochemistry. 37:1998;9371-9378.
45. Snow E. T. A possible role for chromium(III) in genotoxicity. Environ. Health Perspect. 92:1991;75-81.
46. Susa N., Ueno S., Furukawa Y., Ueda J., Sugiyama M. Protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol. 144:1997;377-384.
47. Tamino G., Peretta L., Levis A.G. Effects of trivalent and hexavalent chromium on the physicochemical properties of mammalian cell nucleic acids and synthetic polynucleotides. Chem.-Biol. Interact. 37:1981;309-319.
48. Voitkun V., Zhitkovich A., Costa M. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res. 26:1998;2024-2030.
49. Wise J. P., Leonard J. C., Patierno S. R. Clastogenicity of lead chromate particles in hamster and human cells. Mutat. Res. 278:1992;69-79.
50. Wise J. P., Orenstein J. M., Patierno S. R. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. Carcinogenesis. 14:1993;429-434.
51. Wise J. P., Stearns D. M., Wetterhahn K. E., Patierno S. R. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Carcinogenesis. 15:1994;2249-2254.
52. Xu J., Bubley G. J., Detrick B., Blankenship L. J., Patierno S. R. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA crosslinks and S-phase blockade of the cell cycle. Carcinogenesis. 17:1996;1511-1517.
53. Xu J., Manning F. C. R., Bubley G. J., Patierno S. R. Effects of chromium-damaged DNA templates on DNA replication and transcription. Proc. Am. Assoc. Cancer Res. 36:1996.
54. Yang J.-L., Wang L.-C., Chang C.-Y., Liu T.-Y. Singlet oxygen is the major species participating in the induction of DNA strand breakage and 8-hydroxyguanine adduct by lead acetate. Environ. Mol. Mutagen. 33:1999;194-201.
55. Zelikoff J. T., Li J. H., Hartwig A., Wang X. W., Costa M., Rossman T. G. Genetic toxicology of lead compounds. Carcinogenesis. 9:1988;1727-1732.